NCT06644430
Ablation of Pulmonary Oligometastasis Combined With System for Advanced Hepatocellular Carcinoma
At risk: Primary completion moved 1 year 6 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion dates pushed to Dec 30, 2026
- Eligibility criteria shortened, about 27 words
- Minor Study completion date: Oct 30, 2025 to Dec 30, 2025
- Start date changed from estimate of Nov 4, 2024 to Oct 4, 2024
- Minor Start date: Oct 20, 2024 to Nov 4, 2024v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Progression-Free-Survival
Timeframe: 12 months
Secondary (2)
Overall survival (OS)
Objective response rate (ORR)
Arms and interventions
Ablation+system group
Participants received ablation of plumonary combined systemic therapy
System group
Participants received systemic therapy
Procedures: Ablation
Drugs: system therapy
Sites
1 site in 1 country
- Chinese PLA General hospitalBeijing, Beijing Municipality, China